Bloomberg Intelligence cover image

Intel to Sell 51% Altera Stake to Silverlake

Bloomberg Intelligence

00:00

Challenges in Obesity Medications

This chapter delves into the struggles of a pharmaceutical company in the obesity market, particularly focusing on their products Daniglipron and Lodiglipron. It discusses competitive dynamics, revenue loss forecasts, and the potential growth opportunities in the obesity sector amid challenges posed by larger industry players.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app